CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Previously Reported [Member]	Convertible Preferred Stock	Convertible Preferred Stock Previously Reported [Member]	Common Stock	Common Stock Previously Reported [Member]	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported [Member]	Accumulated Deficit	Accumulated Deficit Previously Reported [Member]	Accumulated other comprehensive income	Accumulated other comprehensive income Previously Reported [Member]
Balance at the beginning at Dec. 31, 2020	$ (78,250)	$ (78,250)					$ 4,157	$ 4,157	$ (82,642)	$ (82,642)	$ 235	$ 235
Balance (in Shares) at Dec. 31, 2020					10,376,000	2,124,000
Balance at the beginning at Dec. 31, 2020			$ 111,432	$ 111,432
Balance (in Shares) at Dec. 31, 2020			104,822,000	21,458,000
Retroactive application of exchange ratio, Shares at Dec. 31, 2020				83,364,000		8,252,000
Stock-based compensation	427						427
Issuance of Series C Convertible Preferred Stock (in Shares)			16,404,000
Issuance of Series C Convertible Preferred Stock			$ 34,793
Common stock warrants issued to customers as consideration	22						22
Common stock warrants related to marketing expense	210						210
Exercise of warrants	5						5
Exercise of warrants (in Shares)					2,457,000
Net loss	(9,267)								(9,267)
Other comprehensive loss	(128)										(128)
Balance at Mar. 31, 2021	(86,981)						4,821		(91,909)		107
Balance (in Shares) at Mar. 31, 2021					12,833,000
Balance at the end at Mar. 31, 2021			$ 146,225
Balance (in Shares) at Mar. 31, 2021			121,226,000
Balance at the beginning at Dec. 31, 2021	$ 449,502				$ 19		604,077		(154,603)		9
Balance (in Shares) at Dec. 31, 2021					193,864,000
Balance (in Shares) at Dec. 31, 2021	0
Stock-based compensation	$ 3,523						3,523
Common stock warrants issued to customers as consideration	2						2
Common stock warrants related to marketing expense	217						217
Reverse recapitalization, net of transaction costs	(70)						(70)
Exercise of options	62						62
Number of Options, Exercised					131,000
ESPP Purchases	488						488
ESPP Purchases (in shares)					75,000
Net loss	(23,394)								(23,394)
Other comprehensive loss	(183)										(183)
Balance at Mar. 31, 2022	$ 430,147				$ 19		$ 608,299		$ (177,997)		$ (174)
Balance (in Shares) at Mar. 31, 2022					194,070,000
Balance (in Shares) at Mar. 31, 2022	0